Association of Antenatal and Postnatal Dexamethasone Exposure With Outcomes in Extremely Low Birth Weight Neonates
* Children’s Medical Center of Dallas, Dallas, Texas
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas
Background. Recent studies of preterm neonates have indicated that antenatal dexamethasone (ADX) may have adverse effects on cranial ultrasound findings at the time of hospital discharge, including periventricular leukomalacia. Furthermore, both ADX and postnatal dexamethasone (PDX) may have adverse effects on subsequent neurodevelopmental outcome.
Objectives. 1) To assess the effects of ADX exposure on cranial ultrasound findings at the time of hospital discharge and 2) to evaluate the individual effects of ADX and/or PDX exposure on subsequent neurodevelopmental outcome in extremely low birth weight (ELBW) neonates in whom confounding risk factors known to influence outcome were controlled.
Methods. One hundred seventy-three ELBW (
1000 g) neonates were studied using a prospectively collected database and hospital and clinic records. Study patients were assigned to 1 of 4 groups according to dexamethasone exposure: group I, no dexamethasone exposure; group II, ADX exposure to hasten fetal lung maturity; group III, PDX exposure for chronic lung disease; group IV, both ADX and PDX exposure. The 4 groups were compared using multinomial logistic regression or analysis of covariance to control for confounding variables. Primary outcome variables were cranial ultrasound findings at hospital discharge and results of developmental testing at 18 to 22 months’ corrected age (Bayley Scales of Infant Development).
Results. Cranial ultrasound results as well as Bayley Scales of Infant Development scores were similar in groups I and II and in groups III and IV. The likelihood of abnormal cranial ultrasound studies and lower scores on neurodevelopmental testing was greater in groups III and IV versus groups I and II. In this study, ADX did not seem to increase the risk of periventricular leukomalacia.
Conclusions. ADX exposure is not associated with an increase in abnormal cranial ultrasound findings in ELBW neonates. PDX exposure, but not ADX exposure, is associated with worse neurodevelopmental outcome in this population. These results are supportive of the recent statement by the American Academy of Pediatrics (Committee on Fetus and Newborn) and the Canadian Paediatric Society (Fetus and Newborn Committee) and emphasize that PDX should be used with caution in ELBW neonates.
Key Words: preterm neonate • corticosteroids • chronic lung disease • neurodevelopment • analysis of variance • ANCOVA • multinomial regression • Bayley • head ultrasound
Abbreviations: ADX, antenatal dexamethasone • RDS, respiratory distress syndrome • PDX, postnatal dexamethasone • CLD, chronic lung disease • ELBW, extremely low birth weight • PVL, periventricular leukomalacia • BSID II, Bayley Scales of Infant Development • MDI, mental development index • PDI, psychomotor development index
Received for publication Aug 30, 2001; Accepted Mar 11, 2001.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  A.J.J.T. Rein, D. Mevorach, Z. Perles, S. Gavri, M. Nadjari, A. Nir, and U. Elchalal Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies: A Prospective, Observational, Fetal Kinetocardiogram-Based Study Circulation, April 14, 2009; 119(14): 1867 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wilson-Costello, M. C. Walsh, J. C. Langer, R. Guillet, A. R. Laptook, B. J. Stoll, S. Shankaran, N. N. Finer, K. P. Van Meurs, W. A. Engle, et al. Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants Pediatrics, March 1, 2009; 123(3): e430 - e437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Lee, B. J. Stoll, S. A. McDonald, R. D. Higgins, and for the National Institute of Child Health and Hum Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants Exposed Prenatally to Dexamethasone Versus Betamethasone Pediatrics, February 1, 2008; 121(2): 289 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Lodygensky, K. Rademaker, S. Zimine, M. Gex-Fabry, A. F. Lieftink, F. Lazeyras, F. Groenendaal, L. S. de Vries, and P. S. Huppi Structural and Functional Brain Development After Hydrocortisone Treatment for Neonatal Chronic Lung Disease Pediatrics, July 1, 2005; 116(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Hall, S. S. Kronsberg, B. A. Barton, J. R. Kaiser, K.J.S. Anand, and for the NEOPAIN Trial Investigators Group Morphine, Hypotension, and Adverse Outcomes Among Preterm Neonates: Who's to Blame? Secondary Results From the NEOPAIN Trial Pediatrics, May 1, 2005; 115(5): 1351 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Bruder, P. C. Lee, and H. Raff Dexamethasone treatment in the newborn rat: fatty acid profiling of lung, brain, and serum lipids J Appl Physiol, March 1, 2005; 98(3): 981 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ho and S. Saigal Current Survival and Early Outcomes of Infants of Borderline Viability NeoReviews, March 1, 2005; 6(3): e123 - e132. [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Bruder, P. C. Lee, and H. Raff Metabolic Consequences of Hypoxia from Birth and Dexamethasone Treatment in the Neonatal Rat: Comprehensive Hepatic Lipid and Fatty Acid Profiling Endocrinology, November 1, 2004; 145(11): 5364 - 5372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vanhaesebrouck, K. Allegaert, J. Bottu, C. Debauche, H. Devlieger, M. Docx, A. Francois, D. Haumont, J. Lombet, J. Rigo, et al. The EPIBEL Study: Outcomes to Discharge From Hospital for Extremely Preterm Infants in Belgium Pediatrics, September 1, 2004; 114(3): 663 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. George, V. Sharma, J. Jacobson, S. Simon, and A. J. Nopper Adverse Effects of Systemic Glucocorticosteroid Therapy in Infants With Hemangiomas Arch Dermatol, August 1, 2004; 140(8): 963 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Neal Jr., G. Weidemann, M. Kabbaj, and D. M. Vazquez Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R375 - R385. [Abstract] [Full Text] [PDF]
|
|
